In this episode, Kyle Buller interviews three past guests: Dr. James Fadiman, Dr. Sam Gandy; and Dr. David Luke. Gandy and Luke recently co-wrote a paper called “Psychedelics as potential catalysts of scientific creativity and insight,” and they wanted to pick the mind of one of the early researchers of psychedelics and creativity: James Fadiman. They discuss the differences between artistic and scientific creativity; how the psychedelic experience is similar to dreaming and the hypnagogic state; microdosing; DMT entity encounters and problem-solving; society’s lost interest in divination; pluralistic perspectivism; why the West’s scientism obsession hurts research; how science has too few mystics and too many technicians; “pseudo-delics”; and the serotonin/depression conundrum.

The post PT353 – Dr. James Fadiman, Dr. Sam Gandy, & Dr. David Luke – Psychedelics and Creativity appeared first on Psychedelics Today.

Previous articlePsychedelic Bulletin #117 – A Deep Dive Into Psilocybin for Alochol Use Disorder; Former MindMed CMO Alleges IP Was Syphoned off to Competitor; ARK Discusses Psychedelics
Next articlePsyBio Therapeutics to Present at Upcoming Investor Events in September 2022